Medical cannabis: what will pharmacy's role be?Subscription
How the UK has realised the benefits of medical cannabis and the involvement pharmacists could have in its supply.
Putting insomnia to bedSubscription
An estimated 30–50% of the population will experience insomnia symptoms at some point in their lives and, in the UK, insomnia rates steadily rise with age. With a 2% increase in sales of over-the-counter sleep aids during 2017, pharmacists are seeing more patients with insomnia symptoms. Here we discuss the health implications of not getting enough sleep and what can be done to help people drift off.
Medicines reuse schemes successfully operate in the United States and Greece, reducing medicines waste and environmental pollution, as well as saving money and providing drugs to thousands of people who could not otherwise afford them. Is there a demand for such a scheme in the UK, and would it be feasible?
Ensuring Gosport is never repeatedSubscription
A more open culture in the health service is essential to help pharmacists highlight problematic prescribing and prevent tragedies such as those at Gosport War Memorial Hospital.
Large differentials in pass rates for particular black and minority ethnic groups are a concern and the regulator needs to do all it can to ensure all students receive the required level of support, regardless of their ethnicity.
Shared decision-making should become a mandatory part of training for all healthcare professionals to improve collaboration with their patients, save the NHS billions, and ultimately improve patient outcomes, say Aseem Malhotra and Sue Bailey.
Simon Dukes, chief executive of the Pharmaceutical Services Negotiating Committee, on how he is going to negotiate a new deal for community pharmacy.
Accurately diagnosing antibiotic allergiesSubscription
Diagnosing true drug allergy can be challenging and it is important that patients are managed appropriately.
A tailored approach can help pharmacists support patients to make better treatment choices, resulting in more successful outcomes.
In these difficult times of limited resources, funding cuts, lower profits and reductions in staff, it may have been some time since you have had a pay increase or even considered requesting one — but that does not mean you do not deserve one.
The online pharmacy Pharmacy2U has been criticised by the advertising watchdog for making “misleading” statements claiming that it could save the NHS £300m.
The pharmacy regulator has been urged to look at its ongoing fitness-to-practise cases to make sure a repeat of the Gosport War Memorial Hospital scandal is not currently happening.
The UK government wants to keep the free movement of seven protected professions — including pharmacists — between the EU and UK after Brexit.
All patients with one or more long-term conditions must have access to a personalised care plan by 2020 to help them take control of their health, a report written by the All-Party Pharmacy Group says.
Pharmacies are being advised to recall all batches of valsartan-containing medicines made by Dexcel Pharma Ltd and Accord Healthcare following an urgent investigation into medicines containing valsartan.
Official figures show the number of adults smoking in England fell by 1.6 million between 2011 and 2017, but falling numbers quit using NHS Stop Smoking Services.
News in brief
A scheme using financial incentives to reduce antibiotic prescribing has worked, Public Health England has said.
Share prices of two of the world’s largest pharmacy and healthcare firms fell after the announcement that retail internet giant Amazon has bought into the prescription drug industry.
Penicillin allergy is associated with an increased risk of methicillin-resistant Staphylococcus aureus and Clostridium difficile mediated by the increased use of ‘broad spectrum’ antibiotics, a study in The British Medical Journal has found.
Representatives from the Pharmacists’ Defence Association Union and senior Boots managers have begun talks to establish how Boots pharmacists are represented in the future.
Official figures show a steep rise in the proportion of drug-related deaths in Scotland in patients who had a gabapentin or pregabalin prescribed in the 90 days before death.